Internal Server Error

MedGenome - About the company

MedGenome is a series E company based in Bengaluru (India), founded in 2013 by Sreedhar Santhosh and Mahesh Pratapneni. It operates as a Provider of DNA sequencing, bioinformatics, and multiomics services. MedGenome has raised $264M in funding from investors like Peak XV Partners, Novo Holdings and HDFC, with a current valuation of $*****. The company has 75 active competitors, including 9 funded and 7 that have exited. Its top competitors include companies like Dr Lal PathLabs, Orange Health and Metropolis India.

Company Details

Provider of DNA sequencing, bioinformatics, and multiomics services. It offers a comprehensive suite of genomic services which include whole genome and exome sequencing, single-cell sequencing, spatial transcriptomics, and immune profiling. It also provides robust bioinformatics support, including analysis pipelines and data visualization tools, to facilitate research and drug discovery. The services are tailored to support research in various areas, including rare disease research, cancer research, and antibody discovery.
Social
XFacebook
Part Of
Registered Address
Sy. Nos. 94/1C and 94/2, Tower 1, Ground Floor, Veerasandra Village, Attibele Hobli, Electronic City Phase-1, Electronics City, Bangalore, Bangalore South, Karnataka, India, 560100
Key Metrics
Founded Year
2013
Location
Bengaluru, India
Stage
Series E
Total Funding
$264M in 10 rounds
Latest Funding Round
Post Money Valuation
$***** as on Dec 18, 2021
Ranked
Annual Revenue
₹100 - ₹500 Cr as on Mar 31, 2025
Employee Count
922 as on May 31, 2025
Investment & Acquisitions
Similar Companies
Sign up to download MedGenome's company profile

MedGenome's funding and investors

MedGenome has raised a total funding of $264M over 10 rounds. Its first funding round was on Aug 20, 2013. Its latest funding round was a Series E round on Jul 21, 2025 for $*****. 3 investors participated in its latest round. MedGenome has 21 institutional investors and 11 angel investors.

Here is the list of recent funding rounds of MedGenome:lockFilter this list
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Jul 21, 2025
7234845
Series E
2588273
8177585
7955303
8917464
Aug 30, 2022
3736314
Series D
7749458
8503632
6793029
Jul 15, 2021
5437476
Series D
5632908
3054374
lockAccess funding benchmarks and valuations. Sign up today!

MedGenome's founders and board of directors

Founder? Claim Profile
The founders of MedGenome are Sreedhar Santhosh and Mahesh Pratapneni. Mahesh Pratapneni, Felix Olale and Vedam Ramprasad are the CEOs of MedGenome.
Here are the details of MedGenome's key team members:

MedGenome's Board of Directors

MedGenome's board has 4 active members. Mahesh Pratapneni is part of team and Navjeewan Jatinder Khosla, Prasad Bhagwan Shejale and Shankar Mahadevappa Prasad are independent board members.
Here is the list of MedGenome's board of directors:
Name
Type
Representing
Status
Duration
Team
-
Current
6y 11m
Independent board member
-
Current
1y 9m
pb{hksf
Independent board member
-
Current
9y 5m
vgnnure
Independent board member
-
Current
6y 4m

MedGenome's employee count trend

MedGenome has 922 employees as of May 25. The total employee count is 5.0% more than what it was in May 24. Here is MedGenome's employee count trend over the years:
Employee count trend for MedGenome
lockUncover MedGenome's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

MedGenome's Competitors and alternates

Top competitors of MedGenome include Dr Lal PathLabs, Orange Health and Metropolis India. Here is the list of Top 10 competitors of MedGenome, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Dr Lal PathLabs
Dr Lal PathLabs
1949, Gurugram (India), Public
Chain of pathology and radiology labs
$13.9M
79/100
2nd
Logo for MedGenome
MedGenome
2013, Bengaluru (India), Series E
Provider of DNA sequencing, bioinformatics, and multiomics services
$264M
70/100
3rd
Logo for Orange Health
Orange Health
2020, Bengaluru (India), Series C
Chains providing at-home diagnostic testing and health checkup services
$77.1M
69/100
4th
Logo for Metropolis India
Metropolis India
1981, Mumbai (India), Public
Chain of diagnostic centers
$232M
68/100
5th
Logo for CORE
CORE
2012, Gurugram (India), Acquired
Laboratory offering biomarker analysis
$17.3M
53/100
6th
Logo for Lilac Insights
Lilac Insights
2011, Mumbai (India), Series A
Provider of genetic diagnostic advisory services for infant
$11M
52/100
7th
Logo for Sterling Accuris Diagnostics
Sterling Accuris Diagnostics
2015, Ahmedabad (India), Series C
Chain of pathology labs
$41.7M
51/100
8th
Logo for Dr Dangs Lab
Dr Dangs Lab
1983, Delhi (India), Unfunded
Provider of diagnostic testing services in various medical specialties
-
-
50/100
9th
Logo for Airmed
Airmed
2016, Ahmedabad (India), Seed
Provider of a chain of diagnostic labs
$1.54M
49/100
10th
Logo for CRL Diagnostics
CRL Diagnostics
2015, Delhi (India), Unfunded
Chain of pathology laboratory services
-
-
49/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on MedGenome's competitors? Click here to see the top ones

MedGenome's Investments and acquisitions

MedGenome has not made any investments yet. MedGenome has made 6 acquisitions.
Here is the list of latest three $acquisitions:lockFilter this list
Date of Investment/Acquisition
Type
Company Name
Founded Year
Location
May 18, 2026
Acquisition
-
Mar 02, 2026
Acquisition
2013
Mumbai (India)
Nov 04, 2025
Acquisition
-
lockWant to know more about where corporates are investing? Sign up today!
See all acquisitions by MedGenome

Reports related to MedGenome

Here is the latest report on MedGenome's sector:

News related to MedGenome

lockFilter this list
Media has covered MedGenome for a total of 8 events in the last 1 year, 2 of them have been about company updates.
•
•
•
ITM Appoints Dr. Celine Wilke as Chief Medical OfficerGlobeNewswire•Apr 01, 2025•ITM, MedGenome
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about MedGenome

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford